Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The insulin sensitivity concept].

A J Scheen1

  • 1Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine, CHU Sart Tilman, Liège, Belgique. andre.scheen@chu.ulg.ac.be

Diabetes & Metabolism
|July 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Insulin resistance, a condition affecting insulin sensitivity, is central to type 2 diabetes and metabolic syndrome. Improving insulin sensitivity is crucial for better glucose control and cardiovascular health in affected individuals.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cardiovascular Risk

Context:

  • Insulin resistance suspected since the 1930s, confirmed with advanced methods.
  • Initially observed in obese and type 2 diabetic patients.
  • Reaven (1988) highlighted insulin resistance's role in various diseases.

Purpose:

  • To review the evolution of understanding insulin resistance.
  • To emphasize its central role in metabolic syndrome.
  • To discuss strategies for improving insulin sensitivity.

Summary:

  • Insulin resistance, a diminished insulin sensitivity, is increasingly recognized beyond diabetes and obesity.
  • It is the core feature of metabolic syndrome, linking cardiovascular risk factors like hypertension and dyslipidemia.

Related Experiment Videos

  • Mechanisms are complex, but improving insulin sensitivity is key.

    • Impact:

    • Enhancing insulin sensitivity can improve blood glucose control in type 2 diabetes.
    • It offers potential for better cardiovascular outcomes in patients with or without diabetes, especially those with metabolic syndrome.
    • Highlights the need for targeted therapeutic strategies.